{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:45:07Z","timestamp":1787993107573,"version":"build-2784847793"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00137","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T05:23:11Z","timestamp":1584595391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG"],"prefix":"10.3389","volume":"11","author":[{"given":"Lan N.","family":"Vuong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toan D.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu N. A.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuong M.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Humaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Yding","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update."},{"key":"B2","doi-asserted-by":"publisher","first-page":"580171","DOI":"10.1155\/2014\/580171","article-title":"Pharmaceutical options for triggering of final oocyte maturation in ART","volume":"2014","author":"Castillo","year":"2014","journal-title":"Biomed Res Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1472-6483(10)61927-X","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers","volume":"4","author":"Trinchard-Lugan","year":"2002","journal-title":"Reprod Biomed Online."},{"key":"B4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/09513599609012319","article-title":"Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration","volume":"10","author":"Weissman","year":"1996","journal-title":"Gynecol Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.rbmo.2014.01.012","article-title":"Improving the luteal phase after ovarian stimulation: reviewing new options","volume":"28","author":"Andersen","year":"2014","journal-title":"Reprod Biomed Online."},{"key":"B6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/humrep\/dez235","article-title":"The early luteal hormonal profile in IVF patients triggered with hCG","volume":"35","author":"Vuong","year":"2019","journal-title":"Hum Reprod."},{"key":"B7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fendo.2018.00092","article-title":"Daytime variation in serum progesterone during the mid-luteal phase in women undergoing in vitro fertilization treatment","volume":"9","author":"Thomsen","year":"2018","journal-title":"Front Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.rbmo.2011.02.001","article-title":"The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"26","year":"2011","journal-title":"Hum. Reprod."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1210\/jc.2013-4086","article-title":"Pharmacokinetics of human chorionic gonadotropin injection in obese and normal-weight women","volume":"99","author":"Shah","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0002-9378(87)80159-X","article-title":"Age-related changes in the female hormonal environment during reproductive life","volume":"157","author":"Musey","year":"1987","journal-title":"Am J Obstet Gynecol."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00137\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T05:23:12Z","timestamp":1584595392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00137\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":10,"alternative-id":["10.3389\/fendo.2020.00137"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00137","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]},"article-number":"137"}}